Open Beta
TREN
MetriLume
TREN

US marketsARDT

SEC-sourced researchBeta

ARDT

Ardent Health, Inc.

Company comparison ↗

Data passport

CIK
0001756655
Exchange
NYSE
Business activity
Services-General Medical & Surgical Hospitals, NEC · SIC 8062
Financial inputs
6/6
Filing date
Sep 29, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 5,409,483,000.0000 USD; December 2024: 5,966,072,000.0000 USD; December 2025: 6,324,339,000.0000 USD6.3B USD0 USD0December 2023December 2024December 2025
ARDT · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20235,409,483,000.0000Mar 16, 2026
December 20245,966,072,000.0000Mar 16, 2026
December 20256,324,339,000.0000Mar 16, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20256,324,339,000.0000135,811,000.0000470,510,000.00005,290,208,000.00003,605,244,000.0000Mar 16, 2026
December 20245,966,072,000.0000210,343,000.0000315,026,000.00004,956,100,000.00003,433,743,000.0000Mar 16, 2026
December 20235,409,483,000.000053,904,000.0000221,698,000.0000——Mar 16, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

61/100
Profitability54
Growth56
Balance sheet32
Cash generation65
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$6.32BJan 1, 2025 – Dec 31, 2025Mar 16, 202610-K
Previous period revenueRevenues$5.97BJan 1, 2024 – Dec 31, 2024Mar 16, 202610-K
Net incomeNetIncomeLoss$135.81MJan 1, 2025 – Dec 31, 2025Mar 16, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$470.51MJan 1, 2025 – Dec 31, 2025Mar 16, 202610-K
Total assetsAssets$5.29BDec 31, 2025Mar 16, 202610-K
Total liabilitiesLiabilities$3.61BDec 31, 2025Mar 16, 202610-K

New filings

Explore methodology ↗